메뉴 건너뛰기




Volumn 33, Issue 5, 2005, Pages 368-371

Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: A potential therapy for primary hyperoxaluria

Author keywords

Hyperoxaluria; Kidney stones; Nephrolithiasis; Pyridoxamine

Indexed keywords

CALCIUM OXALATE; ETHYLENE GLYCOL; GLYCOLIC ACID; OXALIC ACID; PYRIDOXAMINE;

EID: 28644438439     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-005-0493-3     Document Type: Conference Paper
Times cited : (11)

References (11)
  • 1
  • 2
    • 0029739036 scopus 로고    scopus 로고
    • Recurrence rate and risk factors for urinary calculi after extracorporeal shock wave lithotripsy
    • Sun B, Lee YH, Jiaan BP, et al. (1996) Recurrence rate and risk factors for urinary calculi after extracorporeal shock wave lithotripsy. J Urol 156: 903
    • (1996) J Urol , vol.156 , pp. 903
    • Sun, B.1    Lee, Y.H.2    Jiaan, B.P.3
  • 3
    • 0037370267 scopus 로고    scopus 로고
    • Nephrolithiasis: Site of the initial solid phase
    • Bushinsky DA (2003) Nephrolithiasis: site of the initial solid phase. J Clin Invest 111: 602
    • (2003) J Clin Invest , vol.111 , pp. 602
    • Bushinsky, D.A.1
  • 4
    • 10944220190 scopus 로고    scopus 로고
    • Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: A potential therapy for primary hyperoxaluria
    • Chetyrkin SV, Kim D, Belmont J, Scheinman JI, Hudson BG, Voziyan PA (2004) Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Kidney Int 67: 53
    • (2004) Kidney Int , vol.67 , pp. 53
    • Chetyrkin, S.V.1    Kim, D.2    Belmont, J.3    Scheinman, J.I.4    Hudson, B.G.5    Voziyan, P.A.6
  • 5
    • 0021240143 scopus 로고
    • Successful strategies for renal transplantation in primary oxalosis
    • Scheinman JI, Najarian JS, Mauer SM (1984) Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25: 804
    • (1984) Kidney Int , vol.25 , pp. 804
    • Scheinman, J.I.1    Najarian, J.S.2    Mauer, S.M.3
  • 7
    • 0025986684 scopus 로고
    • Primary hyperoxaluria: Therapeutic strategies for the 90s
    • Scheinman JI (1991) Primary hyperoxaluria: therapeutic strategies for the 90s. Kidney Int 40: 389
    • (1991) Kidney Int , vol.40 , pp. 389
    • Scheinman, J.I.1
  • 8
    • 0009697883 scopus 로고
    • Transplantation in primary hyperoxaluria
    • Tejani E, Fine RN (eds). Wiley-Liss, New York
    • Scheinman JI (1994) Transplantation in primary hyperoxaluria. In: Tejani E, Fine RN (eds) Pediatric renal transplantation. Wiley-Liss, New York, p 349
    • (1994) Pediatric Renal Transplantation , pp. 349
    • Scheinman, J.I.1
  • 9
    • 77957251946 scopus 로고    scopus 로고
    • Management of ESRD in primary hyperoxaluria (PH) in the USA in 2001: Results of dialysis, kidney and kidney/liver transplantation
    • ASN/ISN World Congress of Nephrology, San Francisco Calif.
    • Scheinman JI, Payne R, Booth A (2001) Management of ESRD in primary hyperoxaluria (PH) in the USA in 2001: results of dialysis, kidney and kidney/liver transplantation. ASN/ISN World Congress of Nephrology, San Francisco Calif. J Am Soc Nephrol 12: 243A
    • (2001) J Am Soc Nephrol , vol.12
    • Scheinman, J.I.1    Payne, R.2    Booth, A.3
  • 10
    • 0344412436 scopus 로고    scopus 로고
    • Pharmacokinetics, tolerability and biologic activity of oral Pyridorin™, a novel AGE inhibitor, in patients with type 1 diabetes and diabetic nephropathy
    • Degenhardt TP, Khalifah RG, Klaich GM, Schotzinger RJ (2002) Pharmacokinetics, tolerability and biologic activity of oral Pyridorin™, a novel AGE inhibitor, in patients with type 1 diabetes and diabetic nephropathy. J Am Soc Nephrol 13: 652A
    • (2002) J Am Soc Nephrol , vol.13
    • Degenhardt, T.P.1    Khalifah, R.G.2    Klaich, G.M.3    Schotzinger, R.J.4
  • 11
    • 12144263911 scopus 로고    scopus 로고
    • A phase 2 clinical trial of pyridoxamine (Pyridorin™) in type 1 and type 2 diabetic patients with overt nephropathy (PYR-206)
    • Williams ME, Bolton WK, Degenhardt TP, Schotzinger RJ (2003) A phase 2 clinical trial of pyridoxamine (Pyridorin™) in type 1 and type 2 diabetic patients with overt nephropathy (PYR-206). J Am Soc Nephrol 14: 7A
    • (2003) J Am Soc Nephrol , vol.14
    • Williams, M.E.1    Bolton, W.K.2    Degenhardt, T.P.3    Schotzinger, R.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.